• Research ›
• Research Base

Open, Closed, and Published Protocols

Open

• 97609: Impact of Genomics and Exposures on Disparities in Breast Cancer Radiosensitivity (1 credit)
  Current Accrual: 980 out of 1000 patients
• 98110: A Randomized Phase II Dose Finding Study of ArginMax with or without Phosphodiesterase-5 Inhibitors for Its Effect on Erectile Function and Quality of Life in Survivors of Prostate Cancer Previously Treated with Radiotherapy (1 credit)
  Current Accrual: 128 out of 140 patients
• 99211: Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients Receiving Outpatient Treatment: A Pilot Study (1 Credit)
  Current Accrual: 65 out of 146 patients
• 99311: Randomized Placebo-Controlled Phase 2 Pilot Study of Memantine (Namenda) for Smoking Cessation among Cancer Survivors (1 credit)
  Current Accrual: 79 out of 130 patients

---

Closed

• 60A02  Juice Plus, Head and Neck Cancer

• 71103   Depsipeptide, Soft Tissue Sarcoma

• 91105  Donepezil, Brain Tumor Patients

•  97100  Donepezil/ Ginkgo Biloba, Brain Tumor Patients 

• 91202  Thalidomide/Procarbazine, Gliomas

• 97106 ArginMax, Female Cancer Survivors  

• 97102  Oxandrin/ Megace, Solid Tumor
  
  
• 97202  CoQ10, Breast Cancer

• 97211 Donepezil/ Breast Cancer Cognitive Dysfunction

• 97309 Yoga/ Wellness Education, Breast Cancer

• 97405  Soy/ Effexor, Prostate Patients  

• 97509 Armodafinil/ Brain Radiation-Induced Fatigue

• 98301  St. John's Wort, Breast Cancer

• 98308  COLD-fX, CLL 

---

 Publications